REAL-WORLD COSTS IN BIOLOGIC NAIVE PSORIATIC ARTHRITIS PATIENTS INITIATING APREMILAST OR BIOLOGICS IN A US HEALTHCARE CLAIMS DATABASE

被引：0
|
作者：
Kaplan, D. [1 ]
Ung, B. [2 ]
Udeze, C. [3 ]
Pelletier, C. [3 ]
Tian, M. [3 ]
机构：
[1] Adult & Pediat Dermatol, Overland Pk, KS USA
[2] Celgene Corp, Morris Plains, NJ USA
[3] Celgene Corp, Summit, NJ USA
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PSS15
引用
收藏
页码：S888 / S888
页数：1
相关论文
共 50 条
  • [41] Real-world apremilast use in biologic-naïve psoriatic arthritis patients. Data from Spanish clinical practice
    Gratacos-Masmitja, Jordi
    Catalan, Emma Beltran
    Vega, Jose Luis alvarez
    Urruticoechea-Arana, Ana
    Fito, Concepcion
    Maceiras, Francisco
    Otano, Joaquin Maria Belzunegui
    Melon, Julia Fernandez
    Carmona, Eugenio Chamizo
    Hernandez, Miguel angel Abad
    Vilamajo, Inmaculada Ros
    Oreiro, Sonia Castro
    Alfonso, Eva Pascual
    Alonso, Juan Carlos Torre
    REUMATOLOGIA CLINICA, 2024, 20 (01): : 24 - 31
  • [42] Real-world biologic treatment patterns and healthcare resource utilization in psoriasis patients using an insurance claims database in Japan
    Miyazaki, Celine
    Masuda, Junya
    Rodriguez-Rey, Mateo Delclaux
    Stelmaszuk, Marta Natalia
    Freilich, Jonatan
    Tsai, Phiona I-Ching
    Saeki, Hidehisa
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2024, 35 (01)
  • [43] Characterizing patients initiating abaloparatide, teriparatide, or denosumab in a real-world setting: a US linked claims and EMR database analysis
    Imel, E. A.
    Starzyk, K.
    Gliklich, R.
    Weiss, R. J.
    Wang, Y.
    Williams, S. A.
    OSTEOPOROSIS INTERNATIONAL, 2020, 31 (12) : 2413 - 2424
  • [44] Characterizing patients initiating abaloparatide, teriparatide, or denosumab in a real-world setting: a US linked claims and EMR database analysis
    E.A. Imel
    K. Starzyk
    R. Gliklich
    R.J. Weiss
    Y. Wang
    S.A. Williams
    Osteoporosis International, 2020, 31 : 2413 - 2424
  • [45] Real-world Treatment Patterns Among Patients with Psoriatic Arthritis Treated with Biologic Therapies
    Walsh, Jessica
    Cai, Qian
    Fitzgerald, Timothy
    Pericone, Christopher
    Shukla, Pankaj
    Chakravarty, Soumya
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [46] Real-World Characterization of Women with Diagnosed Endometriosis Initiating Therapy with Elagolix Using a US Claims Database
    Surrey, Eric S.
    Soliman, Ahmed M.
    Johns, Beverly
    Vora, Jamie B.
    Taylor, Hugh S.
    Agarwal, Sanjay K.
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2020, 12 : 473 - 479
  • [47] Real-world treatment patterns and healthcare costs of biologics and apremilast among patients with moderate-to-severe plaque psoriasis by metabolic condition status
    Feldman, Steven R.
    Zhang, Jingchuan
    Martinez, Diane J.
    Lopez-Gonzalez, Lorena
    Marchlewicz, Elizabeth Hoit
    Shrady, George
    Mendelsohn, Alan M.
    Zhao, Yang
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2021, 32 (02) : 203 - 211
  • [48] Risk of major adverse cardiovascular events in patients initiating biologics/apremilast for psoriatic arthritis: a nationwide cohort study
    Vegas, Laura Pina
    Le Corvoisier, Philippe
    Penso, Laetitia
    Paul, Muriel
    Sbidian, Emilie
    Claudepierre, Pascal
    RHEUMATOLOGY, 2022, 61 (04) : 1589 - 1599
  • [49] TREATMENT TRENDS IN PSORIATIC ARTHRITIS IN A REAL-WORLD SETTING; RESULTS FROM A HEALTH PROVIDER DATABASE OF THE PSORIATIC ARTHRITIS PATIENTS
    Haddad, Amir
    Tatour, Faten
    Gazitt, Tal
    Feldhamer, Ilan
    Bergman, Irina
    Cohen, Arnon
    Zisman, Devy
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1863 - 1864
  • [50] Treatment patterns, healthcare resource utilization, and healthcare costs among patients with pulmonary arterial hypertension in a real-world US database
    Studer, Sean
    Hull, Michael
    Pruett, Janis
    Koep, Eleena
    Tsang, Yuen
    Drake, William, III
    PULMONARY CIRCULATION, 2018, 9 (01)
12345